Emesto Silver Potato Seed Treatment from Bayer CropScience Receives Japanese MRL Approval

October 26, 2014

RESEARCH TRIANGLE PARK, N.C. (October 27, 2014) – Bayer CropScience announced today that Japan has established Maximum Residue Limits (MRLs) for Emesto® Silver potato seed treatment, effective immediately.

Governments set MRLs to establish safe amounts of pesticide residue that is permitted to remain on acommodity.The recent decision by Japan’s Ministry of Health, Labor and Welfare establishes MRLs for prothioconazole, one of the two active ingredients in Emesto Silver. The MRL for penflufen, the other active ingredient, was established previously.

“We’re excited for the newest Emesto Silver MRL because it gives growers who export to Japan another tool to manage seed and soil-borne diseases,” said Dave Byrum, Bayer CropScience SeedGrowth senior product manager. “Emesto Silver promotes early plant establishment and acts as the first line of defense against tough diseases growers may face throughout the growing season.”

With this new MRL in place, Japan joins the list of major markets with established import tolerance for Emesto Silver. Check the full list of MRLs at www.mrldatabase.com before shipping.

Since its introduction in 2013, Emesto Silver potato seed treatment fungicide has been proven to help growers control diseases. Emesto Silver uses two modes of action to attack the toughest diseases, such as Rhizoctonia, Fusarium and Helminthosporium Silver Scurf, while promoting early emergence, improving early vigor and fostering uniform stands. The new class of chemistry featured in Emesto Silver results in improved plant vitality, increased yield potential and potatoes with a high-quality finish. For additional information on Emesto Silver potato seed treatment fungicide, please visit https://www.bayercropscience.us/products/seed-treatments/emesto-silver.

© 2014 Bayer CropScience LP, 2 T.W. Alexander Drive, Research Triangle Park, NC 27709. Always read and follow label instructions. Bayer, the Bayer Cross and Emesto are registered trademarks of Bayer. Bayer CropScience is committed to bringing new technology and solutions for agriculture and non-agricultural uses. For questions concerning the availability and use of products, contact a local Bayer CropScience representative, or visit Bayer CropScience online at www.bayercropscience.us.


Bayer CropScience Twitter Page:

Bayer CropScience Blog:

Visit the Bayer Connect - Social Hub for all Bayer CropScience social media, recent news, blog posts, videos and more.

About Bayer CropScience
Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. Bayer CropScience, the subgroup of Bayer AG responsible for the agricultural business, has annual sales of EUR 8,819 million (2013) and is one of the world’s leading innovative crop science companies in the areas of seeds, crop protection and non-agricultural pest control. The company offers an outstanding range of products including high value seeds, innovative crop protection solutions based on chemical and biological modes of action as well as an extensive service backup for modern, sustainable agriculture. In the area of non-agricultural applications, Bayer CropScience has a broad portfolio of products and services to control pests from home and garden to forestry applications. The company has a global workforce of 22,400 and is represented in more than 120 countries. This and further news is available at: www.press.bayercropscience.com.

Bayer CropScience Media Hotline, 1-862-404-5118, or

Casey Allen
Bayer CropScience
Tel: (919) 549-2607
Email: casey.allen@bayer.com

Kayla Reed
Porter Novelli
Tel: (404) 995-4509
Email: kayla.reed@porternovelli.com

Find more information at www.bayercropscience.us.

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.